Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2005
08/30/2005US6936441 Genetically engineered cells for use as tools in genetic engineering and human therapeutics
08/30/2005US6936440 Selecting ligand agonists and antagonists
08/30/2005US6936422 Staphylococcus culture; genetic engineering
08/30/2005US6936281 Human mesenchymal progenitor cell
08/30/2005US6936259 For therapy and prophylaxis of bacterial infections
08/30/2005US6936251 Detection using antibodies
08/30/2005US6936248 Methods of inhibiting GPR-9-6 function
08/30/2005CA2294566C Ikk-.alpha. proteins, nucleic acids and methods
08/30/2005CA2111983C Plant-derived glutathione-s-transferase, encoding dna and uses thereof
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/30/2005CA1341489C Family of primate hematopoietic growth factors
08/25/2005WO2005078108A2 Stress resistant plants
08/25/2005WO2005078079A1 Phytate polynucleotides and methods of use
08/25/2005WO2005078073A2 Isolation, expansion and of clonogenic endothelial progenitor cells
08/25/2005WO2005078072A1 Regulatory cell controlling immunological activity of t cell
08/25/2005WO2005078071A1 Laminate of human corneal endothelial cell culture layer and method of constructing the same
08/25/2005WO2005078070A1 Medium for preparing feeder cells for embryonic stem cells and feeder cells
08/25/2005WO2005078069A1 Method for identifying cellular targets
08/25/2005WO2005077462A2 Cd70 inhibition for the treatment and prevention of inflammatory bowel disease
08/25/2005WO2005077404A1 Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
08/25/2005WO2005077048A2 Immune modulation by regulating expression of the “minor” gene in immune dendritic cells
08/25/2005WO2005076981A2 Methods and compositions related to neuronal differentiation
08/25/2005WO2005076905A2 Culture media compositions free of fetal bovine serum
08/25/2005WO2005076845A2 Compositions and methods relating to culturing neural stem cells with bone marrow stromal cells
08/25/2005WO2005063816A3 Monovalent antibody fragments useful as therapeutics
08/25/2005WO2005062918A3 Methods of treating asthma
08/25/2005WO2005062857A3 Creation of a biological atrioventricular bypass to compensate for atrioventricular block
08/25/2005WO2005051412A3 Regulation of sperm function
08/25/2005WO2005041656A3 Methods, compositions and devices for inducing stasis in tissues and organs
08/25/2005WO2005040398A9 Methods for preserving nucleated mammalian cells
08/25/2005WO2005039291A3 Methods, compositions and devices for inducing stasis in cells
08/25/2005WO2005034624A3 Microfabricated compositions and processes for engineering tissues containing multiple cell types
08/25/2005WO2005030982A3 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
08/25/2005WO2005007829A3 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize
08/25/2005WO2004113500A3 B7s1: an immune modulator
08/25/2005WO2004029203A3 Compositions and methods for enrichment of neural stem cells using ceramide analogs
08/25/2005WO2003064621A3 HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
08/25/2005US20050188443 To produce celery plant having herbicide resistance; insect resistance
08/25/2005US20050188438 Compositions and methods using rna interference for control of nematodes
08/25/2005US20050188436 Continuous culture of conifer embryogenic tissue
08/25/2005US20050188433 Expression vector comprising nucleotide sequences coding succinate/fumarate-transport protein for use generating and propagating plants with enhanced germination behavior
08/25/2005US20050188432 Enhancing transcription via TATA Box census element as core of promoter
08/25/2005US20050187454 CMOS-process compatible high-DC surface coating for capacitive detection and stimulation of biological tissues
08/25/2005US20050187379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/25/2005US20050187378 nucleotide sequences encoding oligopeptide sequences which can render fusion partner proteins environmental stress resistant by binding thereto while conserving their intrinsic properties; recombinant vectors, and cells transformed by them
08/25/2005US20050187179 treatment of tumors which have increased Notch expression; administration of either Notch antisense oligonucleotides or monoclonal antibodies directed to Notch along with cell differentiating agent
08/25/2005US20050187175 Methods and compositions for CPG15-2
08/25/2005US20050187163 Proliferation of chondrocytes to increase the biosynthesis of collagen administering angiotensinogen, angiotensin I and II including analogues, fragments and analogues and type 2 receptor agonists; amino acid sequences
08/25/2005US20050186677 Novel mutated mammalian cells and animals
08/25/2005US20050186675 Allelic series of genomic modifications in cells
08/25/2005US20050186674 Patterning substrate and cell culture substrate
08/25/2005US20050186672 Tissue system with undifferentiated stem cells derived from corneal limbus
08/25/2005US20050186671 Automated bioculture and bioculture experiments system
08/25/2005US20050186669 Apparatus and method for preparing and culturing cells
08/25/2005US20050186665 Expressed ligand - vascular intercellular signaling molecule
08/25/2005US20050186664 Albumin fusion proteins
08/25/2005US20050186663 Cystine-knot fold protein
08/25/2005US20050186660 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis
08/25/2005US20050186639 Gene originating in human chondrocyte
08/25/2005US20050186628 Dorsalin-1 polypeptide and uses thereof
08/25/2005US20050186626 Chicken leukemia inhibitory factor (LIF) and gene thereof
08/25/2005US20050186623 Recovering immunoglobulins from hybridoma cell line; bioreactor and heterologous gene expression
08/25/2005US20050186621 Using host cells to propagate preferential viral proteins for use in generating vaccines aganist microorganismal infection
08/25/2005US20050186620 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response
08/25/2005US20050186616 Nucleotide sequences coding cysteine proteinase inhibitors for use in identifying modulators for prevention and treatment of cell proliferative disorders
08/25/2005US20050186575 Corona-virus-like particles comprising functionally deleted genomes
08/25/2005US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity
08/25/2005US20050186563 Expression vector for use as transformation and gene expression tool in genetic engineering; minimum plasmid-based system for the generation of infectious RNA viruses, preferably influenza viruses, from cloned DNA
08/25/2005US20050186560 Mammalian cell expressing viral replication protein for use as tool in identifying modulators for treatment of cell proliferative and autoimmune disorders; immunotherapy
08/25/2005US20050186558 Adenocarcinomal cells for expression of whey protein and/or caseinoglycomacropeptide for use in treatment of diabetes
08/25/2005US20050186553 Isolating leukocytes from plasma using filtration; identifying cells via activated photoactive compounds
08/25/2005US20050186286 By treating separated dermis with a protease and a surfactant simultaneously, it is possible to decellularize dermis substantially completely without greatly denaturing intrinsic collagen structure of dermis while attenuating residual basement membrane components; use in burn treatment
08/25/2005US20050186266 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/25/2005US20050186211 Use of mda-5 as an antiviral and antiproliferative agent
08/25/2005US20050186209 Protein between 30% but less than 100% identical to a human protein, contains a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide
08/25/2005US20050186207 Regulatory T cells suppress autoimmunity
08/25/2005US20050186205 Administering unlabelled anti-CD20 antibody that binds to the CD20 antigen present on lymphoma cells; a second treatment of cyclophosphamide, doxorubicin, vincristine or prednisone
08/25/2005US20050186203 Isolated antibody bound to human insulin-like growth factor-I receptor, identification of its CDRs (complementarity-determining regions), inhibiting the tyrosine kinase activity of the IGF-IR receptor
08/25/2005US20050186192 Administering the vaccine having attenuated T cells reactive against epitopes of myelin basic protein
08/25/2005US20050186187 Altering the expression levels of a protein; modulating the activity of secretory leukocyte protease inhibitor (SLPI), CD53, or Transferrin-1 in a cell and culturing the cells
08/25/2005US20050186186 Tumor cell having DcR3/TR6, a new member of the TNFR family, anchored at its surface
08/25/2005US20050186185 Mammalian cell modified with genes encoding plant late embryogenesis protein HVA1, trehalose transport protein, or a trehalose synthesis pathway; freezing and/or drying organs for storage prior to use
08/25/2005US20050186184 Ex vivo or in vitro culturing of mammalian Boundary Cap cells; detection, diagnosis, monitoring of nervous system or neurodegenerative disorders such as demyelination and pain; tissue engineering; drug screening for genes or proteins
08/25/2005US20050186182 Using granulocyte colony stimulating factor polypeptide, with stromal cell derived factor (SDF-1) polypeptide; to increase the mobilization of c-Kit+ stem cells in the blood, bone marrow, tissue, heart for the production of embryoid body-like cell clusters
08/25/2005US20050186180 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug.
08/25/2005US20050186149 Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
08/25/2005DE19903920B4 Sebozyten, Sebozyten-Zellinie und deren Verwendungen Sebocytes, sebocytes cell line and their uses
08/25/2005DE19833476B4 Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie Genetically modified CD34-negative adherently growing haematopoietic stem cells and their use in gene therapy
08/25/2005CA2558879A1 Regulatory cell controlling immunological activity of t cell
08/25/2005CA2556266A1 Use of luteinizing hormone (lh), and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
08/25/2005CA2555869A1 Culture media compositions free of fetal bovine serum
08/25/2005CA2555699A1 Monoclonal antibody based biomarker discovery and development platform
08/25/2005CA2555376A1 Compositions and methods relating to culturing neural stem cells with bone marrow stromal cells
08/25/2005CA2555365A1 Methods and compositions for treating tumors and metastatic disease
08/25/2005CA2555142A1 Cell proliferation associated with ccx ckr expression
08/25/2005CA2555021A1 Medium for preparing feeder cells for embryonic stem cells and feeder cells
08/25/2005CA2554094A1 Isolation, expansion and use of clonogenic endothelial progenitor cells
08/25/2005CA2550401A1 Method and compositions for detecting botulinum neurotoxin
08/24/2005EP1566453A2 Qualitative differential splicing
08/24/2005EP1566440A2 Human Interleukin-11 Receptor
1 ... 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 ... 1827